Miskowiak, K. W., M. Vinberg, J. Macoveanu, H. Ehrenreich, N. Køster, B. Inkster, O. B. Paulson, L. V. Kessing, A. Skimminge and H. R. Siebner: Effects of erythropoietin on hippocampal volume and memory in mood disorders. In: Biological Psychiatry 78, 4, 270-277 (2015).
Miskowiak, K. W., H. Ehrenreich, L. V. Kessing and M. Vinberg: Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial : Reply. In: Journal of Clinical Psychiatry 76, 6, e835-e836 (2015).
Miskowiak, K. W., M. Vinberg, E. M. Christensen, J. D. Bukh, C. J. Harmer, H. Ehrenreich and L. V. Kessing: Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial. In: Neuropsychopharmacology 39, 6, 1399-1408, Seq. No.: 10.1038/npp.2013.335 (2014).
Miskowiak, K. W., M. Vinberg, C. J. Harmer, H. Ehrenreich and L. V. Kessing: Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression. In: Psychopharmacology 219, 3, 687-698 (2012).
Miskowiak, K. W., M. Vinberg, C. J. Harmer, H. Ehrenreich, G. M. Knudsen, J. Macoveanu, A. R. Hansen, O. B. Paulson, H. R. Siebner and L. V. Kessing: Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder. In: Trials 11, 1, Seq. No.: 97 (2010).
doi: 10.1186/1745-6215-11-97
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.